In a patient with suspected mercury poisoning who only has a single antibody test result, how should this test be interpreted and what is the appropriate diagnostic and treatment approach?

Mercury Poisoning Diagnosis and Management

A single antibody test is not relevant for diagnosing mercury poisoning; instead, obtain a 24-hour urine mercury level (the validated diagnostic test), and if elevated above 20 mcg/L with compatible symptoms, initiate chelation therapy with dimercaptosuccinic acid (DMSA) while removing the patient from the exposure source. 1, 2

Diagnostic Approach

Validated Testing

• 24-hour urine mercury concentration is the validated diagnostic test for mercury poisoning, not antibody testing 2
• Symptomatic patients typically have urine mercury levels greater than 20 mcg/L 1
• Blood mercury levels can be falsely normal even in confirmed mercury poisoning and should not be used to exclude the diagnosis 3
• Avoid post-chelator challenge urine testing (such as DMPS challenge tests), as these are not validated and produce falsely elevated results leading to misdiagnosis and unnecessary chelation 2

Clinical Presentation to Assess

Pediatric patients commonly present with 1, 3:

• Headache
• Anorexia and vomiting
• Personality changes and restlessness
• Acrodynia (painful extremities with pink discoloration)
• Severe hypertension
• Insomnia

Adult patients may be asymptomatic or present with 1:

• Myalgias
• Tremors
• Hypertension
• Nonspecific neuropsychiatric symptoms

Important Diagnostic Pitfalls

• Delays in diagnosis are common because signs and symptoms are nonspecific 1, 4
• A detailed exposure history is critical—ask specifically about skin lightening creams, mercury-containing traditional medicines, hair-dyeing agents, dental amalgam concerns, and occupational exposures 5
• Elevated urinary catecholamines may serve as a surrogate marker for mercury toxicity and can help confirm diagnosis 3

Antibody Testing Context

If the "antibody test" refers to autoimmune antibodies (such as anti-PLA2R, CASPR2, or LGI1):

• These may be positive in mercury-induced immune-mediated complications such as membranous nephropathy or autoimmune encephalitis 6
• However, in mercury-associated membranous nephropathy, patients are typically negative for anti-PLA2R antibody despite having MN on biopsy 5
• A positive autoimmune antibody in the context of mercury exposure suggests immune dysregulation from mercury toxicity rather than primary autoimmune disease 6

Treatment Algorithm

Immediate Actions

1. Remove patient from mercury exposure source immediately—this is the most critical intervention 1
2. Do not wait for confirmatory testing if clinical suspicion is high—begin evaluation and consider early treatment 1, 4

Chelation Therapy Indications

Initiate DMSA (dimercaptosuccinic acid) chelation when 1, 3, 4:

• Urine mercury level is elevated (>20 mcg/L), OR
• Symptoms are profound regardless of initial testing

Treatment Course

• Oral DMSA is the chelation agent of choice 1, 3, 4
• Typical duration: 1 month or longer depending on clinical response 3
• Resolution of symptoms typically occurs within 6 months of diagnosis and treatment initiation 1
• Monitor urine mercury levels and clinical symptoms to evaluate treatment response 3

Multidisciplinary Approach

• Consult medical toxicology early for suspected mercury poisoning 1
• Involve public health officials to identify and remediate exposure sources 1
• Consider nephrology consultation if proteinuria or renal dysfunction develops 6, 5

Renal Complications

If nephrotic syndrome or proteinuria develops 6, 5:

• Most common pathology is minimal change disease (60%), followed by membranous nephropathy (37%) 5
• Mercury detoxification alone achieves complete remission in most patients (87.5%) within 4.5 months 5
• Immunosuppressants may be needed for severe immune-mediated complications 6